Your browser doesn't support javascript.
loading
Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma.
Du, Mingrui; Gu, Jintao; Liu, Chenlin; Liu, Nannan; Yu, Zhe; Zhou, Chengpei; Heng, Wei; Cao, Zhengcong; Wei, Feilong; Zhu, Kailong; Wang, Yingwen; Zhang, Wei; Xue, Xiaochang; Zhang, Yong; Qian, Jixian.
Afiliación
  • Du M; Department of Orthopedics, The Second Affiliated Hospital, The Fourth Military Medical University, Xi'an, China.
  • Gu J; State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
  • Liu C; State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
  • Liu N; State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
  • Yu Z; Experimental Teaching Center of Basic Medicine, The Fourth Military Medical University, Xi'an, China.
  • Zhou C; Department of Orthopedics, The Second Affiliated Hospital, The Fourth Military Medical University, Xi'an, China.
  • Heng W; Department of Orthopedics, The Second Affiliated Hospital, The Fourth Military Medical University, Xi'an, China.
  • Cao Z; Department of Orthopedics, The Second Affiliated Hospital, The Fourth Military Medical University, Xi'an, China.
  • Wei F; State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
  • Zhu K; Department of Orthopedics, The Second Affiliated Hospital, The Fourth Military Medical University, Xi'an, China.
  • Wang Y; Department of Orthopedics, The Second Affiliated Hospital, The Fourth Military Medical University, Xi'an, China.
  • Zhang W; Preclinical School of Medicine, The Fourth Military Medical University, Xi'an, China.
  • Xue X; State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
  • Zhang Y; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, College of Life Sciences, Shaanxi Normal University, Xi'an, 710062, China. xuexch@snnu.edu.cn.
  • Qian J; The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, College of Life Sciences, Xi'an, China. xuexch@snnu.edu.cn.
J Exp Clin Cancer Res ; 41(1): 154, 2022 Apr 23.
Article en En | MEDLINE | ID: mdl-35459258
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Óseas / Doxorrubicina / Osteosarcoma Tipo de estudio: Diagnostic_studies Límite: Adolescent / Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Óseas / Doxorrubicina / Osteosarcoma Tipo de estudio: Diagnostic_studies Límite: Adolescent / Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China